Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/15/2862616/33090/en/Axsome-Therapeutics-Highlights-Innovative-Neuroscience-Portfolio-at-the-American-Academy-of-Neurology-AAN-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/10/2860618/33090/en/Axsome-Therapeutics-to-Report-First-Quarter-2024-Financial-Results-on-May-6.html
https://www.globenewswire.com/news-release/2024/04/01/2855085/33090/en/Axsome-Therapeutics-Initiates-ENGAGE-Phase-3-Trial-of-Solriamfetol-for-the-Treatment-of-Binge-Eating-Disorder.html
https://www.biopharmadive.com/news/axsome-narcolepsy-drug-clinical-trial-results/711249/
https://www.globenewswire.com/news-release/2024/03/25/2851482/33090/en/Axsome-Therapeutics-Announces-Results-of-CRESCENDO-Narcolepsy-Patient-Survey-Demonstrating-Unmet-Needs-in-Treated-Narcolepsy-Type-1-Patients.html
https://www.globenewswire.com/news-release/2024/03/19/2848411/33090/en/Axsome-Therapeutics-Initiates-PARADIGM-Phase-3-Trial-of-Solriamfetol-for-the-Treatment-of-Major-Depressive-Disorder.html
https://www.globenewswire.com//news-release/2024/03/05/2840285/33090/en/Axsome-Therapeutics-to-Present-at-the-Leerink-Partners-Global-Biopharma-Conference.html
https://www.globenewswire.com//news-release/2024/02/27/2835850/33090/en/Axsome-Therapeutics-to-Present-at-the-TD-Cowen-44th-Annual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/02/20/2831680/33090/en/Axsome-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.investors.com/news/technology/axsm-stock-tumbles-on-an-unexpected-setback-for-axsome-alzheimers-drug/